搞钱树
08-01
$中慧生物-B(02627)$
中慧生物招股首日孖展235倍,最终大概率会超购2000倍启动回拨至公开发售50%,甲乙组各41803手。按照20万人申购算,预估一手中签率5%,申购400手稳中一手。冲
【IPO】中慧生物,能否复刻维立志博表现?
中慧生物-B(02627),由于8月5日香港黑色暴雨警告,接联交所通知,公开发售申购期延迟1日,最新申购截止时间为8月6日8点(北京时间),目前孖展超购逾3000倍。【年内医药新股,映恩生物、药捷安康、维立志博均实现上市首日大涨,大家看好中慧生物上市大涨吗?你有参与打新吗?】
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
5
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":462903008227992,"tweetId":"462903008227992","gmtCreate":1754036681997,"gmtModify":1754048772890,"author":{"id":9000000000000221,"idStr":"9000000000000221","authorId":9000000000000221,"authorIdStr":"9000000000000221","name":"搞钱树","avatar":"https://static.tigerbbs.com/82edc4968feb7c0c481f5ad38d9a498b","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":188,"starInvestorFlag":false},"themes":[{"themeId":"c84bf6b420c54df386ed96129eb27e88","categoryId":"7ba93224048e4975aa9a5a60d7f2353b","name":"【IPO】中慧生物,能否复刻维立志博表现?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":c84bf6b420c54df386ed96129eb27e88}&rnconfig={\"headerBarHidden\": true}","description":"中慧生物-B(02627),由于8月5日香港黑色暴雨警告,接联交所通知,公开发售申购期延迟1日,最新申购截止时间为8月6日8点(北京时间),目前孖展超购逾3000倍。【年内医药新股,映恩生物、药捷安康、维立志博均实现上市首日大涨,大家看好中慧生物上市大涨吗?你有参与打新吗?】","image":"https://static.tigerbbs.com/b32d71f11ad9e1cd466781f24a032d65"}],"images":[],"coverImages":[],"html":"<html><head></head><body><p style=\"text-align: left\"> <a data-mention-id=\"02627\" rel=\"noopener noreferrer\" class=\"teditor-mention\" data-mention-name=\"中慧生物-B\" target=\"_blank\" href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$</a><span>中慧生物招股首日孖展235倍,最终大概率会超购2000倍启动回拨至公开发售50%,甲乙组各41803手。按照20万人申购算,预估一手中签率5%,申购400手稳中一手。冲</span></p></body></html>","htmlText":"<html><head></head><body><p style=\"text-align: left\"> <a data-mention-id=\"02627\" rel=\"noopener noreferrer\" class=\"teditor-mention\" data-mention-name=\"中慧生物-B\" target=\"_blank\" href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$</a><span>中慧生物招股首日孖展235倍,最终大概率会超购2000倍启动回拨至公开发售50%,甲乙组各41803手。按照20万人申购算,预估一手中签率5%,申购400手稳中一手。冲</span></p></body></html>","text":"$中慧生物-B(02627)$中慧生物招股首日孖展235倍,最终大概率会超购2000倍启动回拨至公开发售50%,甲乙组各41803手。按照20万人申购算,预估一手中签率5%,申购400手稳中一手。冲","highlighted":1,"essential":2,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/462903008227992","repostId":0,"isVote":1,"tweetType":1,"viewCount":14016,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02627"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":true,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":159,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/462903008227992"}
精彩评论